Aūra TB-500
Aūra Mobility (TB-500) is a synthetic peptide fragment modeled after thymosin beta-4 and widely used in research focused on soft-tissue dynamics, mobility, and structural support. In experimental models, TB-500 is examined for its potential to influence cell migration, tissue remodeling, and recovery-related signaling pathways. Researchers often include it in studies looking at how tissues respond to stress, strain, and overuse in controlled laboratory environments. All observations are derived from non-clinical research and are not intended to represent medical outcomes.
Research Characteristics:
- Studied for its role in cell migration, cytoskeletal organization, and tissue-remodeling pathways in preclinical models.
- Used in soft-tissue and joint frameworks exploring mobility, flexibility, and recovery-oriented signaling after mechanical or exercise-induced stress.
- Evaluated for potential effects on local blood flow, tissue integrity, and structural support in experimental settings.
- Frequently paired with other research peptides in performance, resilience, and repair-focused research programs.
Each batch of Aūra Mobility (TB-500) is supported by a Certificate of Analysis (COA) summarizing third-party analytical testing, including identity confirmation and purity assessment. COAs are provided strictly for research documentation and do not constitute approval for human or veterinary use.
View COA sample
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as such.
Always quality-tested, verified with third-party COAs
At every stage, Aūra Peptides batches are screened by independent labs for identity, purity, sterility, and endotoxins. Each lot is released only after it meets strict research-grade specifications and is backed by a third-party Certificate of Analysis (COA) for full transparency.
This multi-step process helps ensure that what’s on the label is exactly what’s in the vial—so researchers can focus on data, not doubt.
Identity Test
PassedVerifies the peptide’s sequence and structure so the correct compound is present in each vial.
Purity Test
PassedMeasures purity and concentration to confirm ≥99% purity on qualifying batches.
Sterility Test
PassedScreens for bacteria, fungi, and other microorganisms to verify sterile handling.
Endotoxicity
PassedTests for lipopolysaccharides (LPS) to ensure endotoxin levels stay within research limits.